Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any
discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Summary of Non-Consolidated Financial Results
for the Six Months Ended September 30, 2022
(Based on Japanese GAAP)
October 31, 2022
Company name:
DAIKEN MEDICAL CO., LTD.
Stock exchange listing: Tokyo
Stock code:
Representative:

7775
President

URL

https://www.daiken-iki.co.jp
Keiichi Yamada

Inquiries:

General Manager Finance and Accounting
Division

Toshikazu Itami

TEL

Scheduled date to file Quarterly Securities Report:
Scheduled date to commence dividend payments:

November 1, 2022
December 1, 2022

Preparation of supplementary material on quarterly financial results:
Holding of quarterly financial results meeting:Yes
No0725-30-3574(Amounts less than one million yen are rounded down)
1. Non-consolidated financial results for the six months ended September 30, 2022 (from April 1, 2022 to September 30, 2022)(1) Non-consolidated operating results (cumulative)
Percentages indicate year-on-year changes
Net sales
Six months ended September 30, 2022
Six months ended September 30, 2021

Millions of yen
4,454
4,086

Operating profit% Millions of yen
9.0605
8.3
565

Earnings per share

Profit% Millions of yen
7.0
429
15.7
400%
7.3
14.2

Diluted earnings per share

Yen
14.94
13.93

Six months ended September 30, 2022
Six months ended September 30, 2021

Ordinary profit% Millions of yen
7.060525.0
565

Yen––(2) Non-consolidated financial position
Total assets

Net assets

Millions of yen
10,84010,920

As of September 30, 2022
As of March 31, 2022

Equity ratio

Millions of yen
6,566
6,446%
60.4
59.0

2. Cash dividends
Annual dividends per share

Year ended March 31, 2022
Year ending March 31, 2023

1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Yen––

Yen
9.00
9.00

Yen–

Yen
11.00

Yen
20.00

–

11.00

20.00

Year ending March 31, 2023 (Forecast)Total

3. Forecast of non-consolidated financial results for the year ending March 31, 2023 (from April 1, 2022 to March 31, 2023)
Percentages indicate year-on-year changes
Net sales
Full year

Millions of yen
9,000

Operating profit% Millions of yen
5.4
1,200

Ordinary profit% Millions of yen
4.3
1,2001Profit% Millions of yen
4.1840Earnings per share%
1.1

Yen
29.24

4. Notes(1) Application of special accounting methods for preparing quarterly non-consolidated financial statements: Yes(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
NoChanges in accounting policies due to revisions to accounting standards and other regulations:
Changes in accounting policies due to other reasons:
Changes in accounting estimates:

NoNo

Restatement of prior period financial statements:

No(3) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2022

31,840,000 shares As of March 31, 2022

31,840,000 shares

Number of treasury shares at the end of the period
As of September 30, 2022

3,111,560 shares As of March 31, 2022

3,111,559 shares

Average number of shares during the period (cumulative from the beginning of the fiscal year)
Six months ended September 30, 2022

28,728,441 shares Six months ended September 30, 2021

228,728,441 shares

Quarterly non-consolidated financial statements
Non-consolidated balance sheets(Thousands of yen)
As of March 31, 2022

As of September 30, 2022

AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade

2,518,589
1,346,167

2,282,527
1,271,060

Electronically recorded monetary claims - operating
Finished goods

1,085,208
973,067

1,234,884
1,024,513

Work in processRaw materials

72,279499,189

86,101
543,921

Other
Allowance for doubtful accounts

78,024(91)

87,072(91)

6,572,435

6,529,990

1,937,619
1,703,670

1,893,120
1,703,670

Total current assets
Non-current assets
Property, plant and equipment
Buildings, net
Land
Other, net

478,110488,476

4,119,400

4,085,267

Intangible assets

15,135

11,898Investments and other assets
Deferred tax assets

160,449

160,449

78,033(24,650)

77,149(24,650)

Total property, plant and equipment

Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets

3

213,831212,948

4,348,367

4,310,114

10,920,803

10,840,104

(Thousands of yen)
As of March 31, 2022

As of September 30, 2022

Liabilities
Current liabilities
Notes and accounts payable - trade463,151

463,983

560,469
1,000,000

581,3131,200,000

Current portion of long-term borrowings
Income taxes payable

597,826
212,541

419,578
196,077

Accrued expenses
Other70,899
246,349

65,857
218,568

Total current liabilities

3,151,237

3,145,379

Non-current liabilities
Long-term borrowings

1,280,033

1,090,043

43,401

38,316

1,323,434

1,128,359

4,474,671

4,273,738

Share capital
Capital surplus

495,875
400,875

495,875
400,875

Retained earnings
Treasury shares

7,368,595(1,826,582)

7,481,867(1,826,582)

Total shareholders' equity

6,438,763

6,552,034

Electronically recorded obligations - operating
Short-term borrowings

Other
Total non-current liabilities
Total liabilities
Net assets
Shareholders' equity

Share acquisition rights
Total net assets
Total liabilities and net assets

4

7,368

14,331

6,446,131

6,566,365

10,920,803

10,840,104

Non-consolidated statements of income (cumulative)(Thousands of yen)Six months ended

Six months ended

September 30, 2021

September 30, 2022

Net sales
Cost of sales

4,086,178
2,268,555

4,454,775
2,613,071

Gross profit

1,817,622

1,841,703

Selling, general and administrative expenses

1,252,281

1,236,682

565,340

605,021

Interest income
Compensation income

0867

0733

Foreign exchange gains
Gain on forfeiture of unclaimed dividends

213544711
261Miscellaneous income

506

271

2,132

1,978

Interest expenses
Other

1,962
146

1,971
–

Total non-operating expenses

2,109

1,971

565,364

605,028691

50

Operating profit
Non-operating income

Total non-operating income
Non-operating expenses

Ordinary profit
Extraordinary losses
Loss on retirement of non-current assets

691

50

Profit before income taxes

Total extraordinary losses

564,672

604,978

Income taxes

164,408

175,694

Profit400,264

429,2845

Non-consolidated statements of cash flows(Thousands of yen)Six months ended

Six months endedSeptember 30, 2021

September 30, 2022

Cash flows from operating activities
Profit before income taxes

564,672

604,978

Depreciation
Share-based payment expenses

158,755–

146,240
6,963

Increase (decrease) in provision for sales allowanceInterest and dividend income(179,346)
(0)

–(0)

Interest expenses
Decrease (increase) in trade receivables

1,962
267,140

1,971(74,569)

Decrease (increase) in inventories
Increase (decrease) in trade payables(150,594)
3,012(109,998)
22,697

Loss on retirement of non-current assets
Decrease (increase) in accounts receivable - other

691
1,435

50
(1,430)

Increase (decrease) in accounts payable - other
Increase (decrease) in accrued expenses(10,551)(111,814)(7,742)(5,041)

33,626(28,025)

Increase/decrease in consumption taxes payable/consumption
taxes refund receivable
Other, net(24,856)(10,002)

Subtotal

554,132

546,090

Interest and dividends received

00

Interest paid
Income taxes paid

(2,022)(78,865)(1,934)(195,526)

Net cash provided by (used in) operating activities

473,244348,629(79,375)(103,087)

(344)
(294)

(1,100)(312)

Proceeds from refund of guarantee deposits
Payments for asset retirement obligations

12,845(6,479)466–

Net cash provided by (used in) investing activities(73,648)(104,033)(380,142)(368,238)(315,855)
500,000(306,762)
200,000(6,027)–(5,657)(0)(202,024)(480,658)

Cash flows from investing activities
Purchase of property, plant and equipment
Purchase of intangible assets
Payments of guarantee deposits

Cash flows from financing activities
Repayments of long-term borrowingsDividends paid
Net increase (decrease) in short-term borrowings
Repayments of lease liabilities
Purchase of treasury shares
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents

197,571(236,061)

Cash and cash equivalents at beginning of period

2,170,643

2,518,589

Cash and cash equivalents at end of period

2,368,214

2,282,527

6